Study on Immunoregulation by Method of Promoting Blood Flow and Dissipating Phlegm among Rats with Chronic Pelvic Inflammatory Disease
10.11842/wst.2013.09.032
- VernacularTitle:活血化瘀法对慢性盆腔炎大鼠免疫调节的实验研究
- Author:
Haiqin ZHANG
;
Ruifen LIU
- Publication Type:Journal Article
- Keywords:
Method of promoting blood flow and dissipating phlegm;
chronic pelvic inflammatory disease;
CD4 +CD25+ Treg;
erythrocyte immunology
- From:
World Science and Technology-Modernization of Traditional Chinese Medicine
2013;(9):2042-2046
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to explore the effect on immunological function of T lymphocyte subpopulation and erythrocyte by the method of promoting blood flow and dissipating phlegm of rat with chronic pelvic inflammatory dis-ease (PID). A mixture of bacteria combined with mechanical injury was used in the establishment of a total of 75 Wistar chronic PID rat models. The rats were divided into the normal group, sham-operation group, model group, Gui-Zhi Fu-Ling Capsule (GZFLC) group, Shao-Fu Zhu-Y u Capsule (SFZYC) group, Jin-Gang-Teng Capsule (JGTC) group, and the control group of GZFLC, SFZYC, and JGTC. Intragastric administration of each medication was given according to different groups. The percentage of amount of CD3+, CD4+, CD8+and CD4+CD25+regulatory T cell (Treg) in the spleen of rats was observed in each group. The RBC-C3bRR and RBC-ICR in the blood serum of rats were also observed. The results showed that medications used in all treatment group significantly increased the percentage of amount of CD3+, CD4+ and CD4/CD8 ratio (P< 0.05) and reduced the percentage of amount of CD8+(P< 0.05). GZFLC has significantly decreased the abnormal increased percentage of the amount of CD4+CD25+ Treg. GZFLC and SFZYC significantly increased RBC-C3bRR (P< 0.05) and decreased RBC-ICR (P< 0.05). It was con-cluded that the prescription of promoting blood flow and dissipating phlegm can treatment chronic PID by adjusting immunity of T lymphocyte subpopulation and erythrocyte.
